Global Next-Generation Sequencing (NGS) Services Market To Witness the Highest Growth Globally in Coming Years

Next-Generation Sequencing (NGS) Services with the aid of advanced technology is a revolution in biotechnology. Massively parallel sequencing with high-Throughput sequencing is any of a number of high-throughput strategies for DNA sequence analysis employing the technique of massively parallel sequencing; it's also known as second-generation sequencing or next-generation sequencing. The sequencing methods may employ any one of them: bacterial, fungi, viral, or endoscope sequencing. The tools are used to sequence DNA fragments, and then they are mapped according to their positions.

Get A Sample PDF Report: https://www.worldwidemarketreports.com/sample/520399

The global Next-Generation Sequencing (NGS) Services market focuses on six regions, such as North America, Asia Pacific, South America, Europe, the Middle East, and Africa.

Drivers:

The main factor influencing the growth of the Next-Generation Sequencing (NGS) Services is the diversified application of the services in diagnostics. The low cost of sequencing has led to an increase in the applications of NGS in the diagnosis of diseases. Owing to the high increase of critical diseases such as cancer, the demand for NGS is also increasing. For instance, according to National Cancer Institute, in 2018, there were approximately 18.1 million new cancer cases worldwide and approximately 9.5 million cancer-related deaths. NGS is used in prenatal testing, genetic testing, and other medical applications. Which is expected to boost the market growth of Next-Generation Sequencing (NGS) Services.

Restraints:

Less knowledge related to the application of NGS is the main restraining factor hindering the growth of the Next-Generation Sequencing (NGS) Services market.

Regional Insights:

North America is expected to hold a significant share of the Next-Generation Sequencing (NGS) Services market owing to the incidence rate of chronic diseases in the area. For instance, according to National Cancer Institute, in 2020 around 1.8 million people were diagnosed with cancer in the United States. Among which, 2620 men and 276,480 women were diagnosed with breast cancer, making it the most common form of cancer in the region.

Asia Pacific is expected to witness significant growth in the Next-Generation Sequencing (NGS) Services market, owing to the technological advancements and the implication of NGS in the region

Buy Now: https://www.worldwidemarketreports.com/buy/520399

Competitive Section:

Key players operating in the global Next-Generation Sequencing (NGS) Services market include GATC Biotech AG, Novogene Corporation, QIAGEN, Illumina, Inc., GENEWIZ, Inc., Macrogen Inc., PerkinElmer, Inc., Eurofins Scientific SE, and BGI

In June 2019, Saphetor partnered with Swift Biosciences Inc. to standardize and accelerate data interpretation solutions.

In January 2019, Pierian Dx partnered with Illumina for providing the consumers with informatics services related to the oncology products of Illumina.

Contact Us:

Mr. Shah
Worldwide Market Reports,
Tel: U.S. +1-415-871-0703 / U.K. +44-203-289-4040 / Japan +81-50-5539-1737
Email: sales@worldwidemarketreports.com

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provides our diverse range of clients from across all industries with vital decision-making insights to plan and align their market strategies in line with current market trends.

This release was published on openPR.